PATENT CLAIM ANALYSIS

Application Number: 15777069
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "456000"]

Abstract:
The invention is directed to a method of treating Alzheimer's Disease by administering to a subject in need thereof a therapeutically effective amount of cromolyn and optionally ibuprofen. The cromolyn may be in the form of cromolyn sodium and administered by inhalation.

Claim (Index 19):
The method according to  claim 3 , wherein the ibuprofen achieves an average C max  ibuprofen concentration in plasma of about 1091 ng/ml.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 93.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15902486', '15895312', '15902498', '14437316', '15360451']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8007851426144718
- 35 USC 102 Novelty (BERT): 0.5284213765917256
- Combined Prediction Score: 0.7735487660121971
- Mean Citation Score: 341.847784
- Max Citation Score: 342.78726
- Similarity Product: 233.2944054302573

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test